Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Combined Pharmacologic Inhibition of Bcl-Xl/Bcl-2 and mTORC1/2 Survival Signals Trigger Apoptosis in BCR-ABL1 + in Vitro Models of Blast Crisis Chronic Myelogenous Leukemia (CML-BC), and Primary CD34 + /CD38 − Stem and CD34 + progenitor Cells From CML-BC Patients

Jason G Harb, Ph.D, Paolo Neviani, PhD, Claudia S Huettner, PhD, Guido Marcucci, MD, Danilo Perrotti, MD, Ph.D

Blood (2011) 118 (21): 2738.

https://doi.org/10.1182/blood.V118.21.2738.2738

Published: 2011

Journal Articles

Leukemia-Induced Alterations in Bone Marrow Cytokine and Chemokine Levels Contribute to Altered Stem Cell Lodgment and Impairment of Normal Stem Cell Growth in CML

Bin Zhang, Yin Wei Ho, Tessa L. Holyoake, PhD, FRCP, FRCPath, Claudia S Huettner, PhD, Ravi Bhatia, MD

Blood (2011) 118 (21): 962.

https://doi.org/10.1182/blood.V118.21.962.962

Published: 2011

Journal Articles

A Novel Role for Bcl-x L in the Context of p210 BCR/ABL B Cell Acute Lymphoblastic Leukemia (B-ALL).

Jason G. Harb, PhD, Brenda I. Chyla, PhD, Claudia S. Huettner, PhD

Blood (2007) 110 (11): 156.

https://doi.org/10.1182/blood.V110.11.156.156

Published: 2007

Journal Articles

Reversible Transplantable Chronic Phase CML-Like Disease in SCLtTA/BCR-ABL Transgenic Mice.

Mirle Schemionek, Jörg Stypmann, MD, Sven Hermann, MD, Christian Elling, Nicole Bäumer, PhD, Tilmann Spieker, MD, Joachim R. Göthert, MD, Martin Stehling, PhD, Claudia S. Huettner, PhD, Michael Schäfers, MD, Daniel G. Tenen, MD, Wolfgang E. Berdel, MD, Tessa L. Holyoake, MD, Carsten Müller-Tidow, MD, Hubert Serve, MD, Steffen Koschmieder, MD

Blood (2007) 110 (11): 1002.

https://doi.org/10.1182/blood.V110.11.1002.1002

Published: 2007

Journal Articles

Decitabine and Vitamin D3 Differentially Increase C-Jun, PU.1, and Sp1 Hematopoietic Transcription Factors To Induce Monocytic Differentiation.

Steffen Koschmieder, MD, Shuchi Agrawal, Hanna S. Radomska, PhD, Claudia S. Huettner, PhD, Daniel G. Tenen, MD, Oliver G. Ottmann, MD, Wolfgang E. Berdel, MD, Hubert L. Serve, MD, Carsten Mueller-Tidow, MD

Blood (2006) 108 (11): 2223.

https://doi.org/10.1182/blood.V108.11.2223.2223

Published: 2006

Journal Articles

Bcl-x Is Indispensable for the Development of Natural Killer Cells.

Jason G. Harb, PhD, Malarkannan Subramaniam, PhD, Claudia S. Huettner, PhD

Blood (2005) 106 (11): 340.

https://doi.org/10.1182/blood.V106.11.340.340

Published: 2005

Journal Articles

Reversible Expansion of Hematopoietic Stem Cells (HSC) and CML-Like Disease in Transgenic Mice Expressing BCR-ABL under the Control of the SCL 3′ Enhancer.

Steffen Koschmieder, MD, Berthold Goettgens, PHD, Pu Zhang, MD, Tajhal Dayaram, Kristin Geary, Anthony R. Green, MD, PHD, Daniel G. Tenen, MD, Claudia S. Huettner, PHD

Blood (2004) 104 (11): 715.

https://doi.org/10.1182/blood.V104.11.715.715

Published: 2004

NARROW

Combined Pharmacologic Inhibition of Bcl-Xl/Bcl-2 and mTORC1/2 Survival Signals Trigger Apoptosis in BCR-ABL1 + in Vitro Models of Blast Crisis Chronic Myelogenous Leukemia (CML-BC), and Primary CD34 + /CD38 − Stem and CD34 + progenitor Cells From CML-BC Patients

Leukemia-Induced Alterations in Bone Marrow Cytokine and Chemokine Levels Contribute to Altered Stem Cell Lodgment and Impairment of Normal Stem Cell Growth in CML

A Novel Role for Bcl-x L in the Context of p210 BCR/ABL B Cell Acute Lymphoblastic Leukemia (B-ALL).

Reversible Transplantable Chronic Phase CML-Like Disease in SCLtTA/BCR-ABL Transgenic Mice.

Decitabine and Vitamin D3 Differentially Increase C-Jun, PU.1, and Sp1 Hematopoietic Transcription Factors To Induce Monocytic Differentiation.

Bcl-x Is Indispensable for the Development of Natural Killer Cells.

Reversible Expansion of Hematopoietic Stem Cells (HSC) and CML-Like Disease in Transgenic Mice Expressing BCR-ABL under the Control of the SCL 3′ Enhancer.

Email alerts

ASH Publications

American Society of Hematology

Combined Pharmacologic Inhibition of Bcl-Xl/Bcl-2 and mTORC1/2 Survival Signals Trigger Apoptosis in BCR-ABL1 + in Vitro Models of Blast Crisis Chronic Myelogenous Leukemia (CML-BC), and Primary CD34 + /CD38 − Stem and CD34 + progenitor Cells From CML-BC Patients

Leukemia-Induced Alterations in Bone Marrow Cytokine and Chemokine Levels Contribute to Altered Stem Cell Lodgment and Impairment of Normal Stem Cell Growth in CML

A Novel Role for Bcl-x L in the Context of p210 BCR/ABL B Cell Acute Lymphoblastic Leukemia (B-ALL).

Reversible Transplantable Chronic Phase CML-Like Disease in SCLtTA/BCR-ABL Transgenic Mice.

Decitabine and Vitamin D3 Differentially Increase C-Jun, PU.1, and Sp1 Hematopoietic Transcription Factors To Induce Monocytic Differentiation.

Bcl-x Is Indispensable for the Development of Natural Killer Cells.

Reversible Expansion of Hematopoietic Stem Cells (HSC) and CML-Like Disease in Transgenic Mice Expressing BCR-ABL under the Control of the SCL 3′ Enhancer.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only